Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC

被引：0

作者：

Cardona, A. F. ^{[1
]}

Arrieta, O. G. ^{[2
]}

Ruiz-Patino, A. ^{[3
]}

Zatarain Barron, Z. L. ^{[2
]}

Rojas, L. L. ^{[4
]}

Corrales, L. ^{[5
]}

Martin, C. ^{[6
]}

Barron, F. ^{[2
]}

Sotelo, C. ^{[7
]}

Rodriguez, J. ^{[7
]}

Ricaurte, L. ^{[7
]}

Freitas, H. ^{[8
]}

Cordeiro De Lima, V. ^{[8
]}

Mas, L. ^{[9
]}

Avila, J. ^{[7
]}

Bravo, M. ^{[7
]}

Mayorga, D. ^{[7
]}

Archila, P. ^{[1
]}

Otero, J. ^{[3
]}

Carranza, H. ^{[10
]}

Vargas, C. ^{[3
]}

Rosell, R. ^{[11
]}

机构：

[1] Ficmac, Med Oncol, Bogota, Colombia

[2] Inst Nacl Cancerol, Mexico City, DF, Mexico

[3] Univ El Bosque, Mol Oncol & Biol Syst Res Grp Fox G, Bogota, Colombia

[4] Clin Colsanitas, Oncol Dept, Bogota, Colombia

[5] Hosp San Juan Dios, San Jose, Costa Rica

[6] Alexander Fleming Inst, Buenos Aires, DF, Argentina

[7] Ficmac, Bogota, Colombia

[8] AC Camargo Canc Ctr, Clin Res Unit, Sao Paulo, Brazil

[9] Natl Canc Inst Peru, Lima, Peru

[10] Clin Country, Bogota, Colombia

[11] Quiron Dexeus Univ Inst, Med Oncol, Ior, Barcelona, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

Non small cell lung cancer; Inmunooncology; HLA-A;

D O I：

10.1016/j.jtho.2019.08.2129

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP1.04-44

引用

页码：S971 / S971

页数：1